EVA Therapeutics, Inc

EVA Therapeutics (Equitable Vaccine Access) aims to become a global leader in computational vaccine design for LMIC-focused diseases, accelerating solutions for neglected pathogens and supporting equitable vaccine access worldwide. We are building a pipeline of affordable, scalable vaccine candidates ready for downstream partners to manufacture and distribute in LMIC markets.